Skip to content

Study of atrial rhythm episodes in patients receiving different types of pacemaker pacing

Study of atrial high-rate episodes burden in patients undergoing concurrent Bachmann bundle area pacing and left bundle branch pacing compared with Bachmann bundle area pacing only and conventional pacing

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/07/113229
Enrollment
50
Registered
2026-07-02
Start date
Unknown
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I446- Other and unspecified fascicular block

Interventions

Intervention1: Nil: Nil

Sponsors

Kauvery Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Adult patients with a clear indication for permanent pacing according to ESC guidelines for management of conduction disturbances such as symptomatic bradycardia complete atrioventricular block or sinus node dysfunction. Patients should be in sinus rhythm at the time of implantation with no documented history of atrial fibrillation before implantation in medical history ECG Holter or telemetry. Patients should be able to comply with follow up for at least 24 months after implantation and should provide written informed consent to participate in the study.

Exclusion criteria

Exclusion criteria: Patients with history of atrial fibrillation before implantation including permanent or paroxysmal atrial fibrillation documented on ECG Holter or telemetry. Patients with prior pharmacological or interventional treatment for atrial fibrillation such as antiarrhythmic drugs or catheter ablation. Patients unable to comply with long term follow up or follow up visits. Patients with contraindications to pacemaker lead placement at selected pacing sites. Patients participating in another study that could influence the results. Patients with previous cardiac device implantation.

Design outcomes

Primary

MeasureTime frame
Total cumulative atrial high-rate episode AHRE time defined as the sum of durations of all device detected atrial high rate episodes with individual episode duration greater than 6 minutes expresses in minutes or hoursTimepoint: At baseline, 3 months, 12 months , and 24 months post pacemaker implantation

Secondary

MeasureTime frame
Incidence of progression to clinically documented atrial fibrillation confirmed by ECG or HolterTimepoint: Up to 24 months;Device or procedure related complications and all cause mortalityTimepoint: Up to 24 months;Echocardiographic markers including left atrial reservoir strain and volume indexTimepoint: Up to 24 months

Countries

India

Contacts

Public ContactDr Deep Chandh Raja S

Kauvery Hospital

drdeepchandh@kauveryhospital.com9936572236

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Aug 10, 2026